KEITH FLAHERTY

Profile

First Name

: KEITH

Middle Name

:

Last Name

: FLAHERTY

Related Companies
Titles
Company Name
Related People
DIRECTOR
CLOVIS ONCOLOGY, INC.
ANDREW R. ALLEN, BRIAN G. ATWOOD, M. JAMES BARRET, JAMES C. BLAIR, GINGER L. GRAHAM, STEVEN L. HOERTER, GILLIAN C. IVERS-READ, PAUL KLINGENSTEIN, PATRICK J. MAHAFFY, ERLE T. MAST, EDWARD J. MCKINLEY, THORLEF SPICKSCHEN
DIRECTOR
LOXO ONCOLOGY, INC.
JAMES BARRETT, JOSHUA H. BILENKER, DAVID BONITA, STEVEN ELMS, DOV GOLDSTEIN, AVI NAIDER
DIRECTOR
STRATA ONCOLOGY, INC.
WILLIAM BURKOTH, JAN GARFINKLE, MATTHEW MARTIN, CHRISTOPHER O-DONNELL, JAMES PAVLIK, DANIEL RHODES, DAVID RUBIN, PREM TUMKOSIT, NICOLE WALKER, JEFFREY WILLIAMS
DIRECTOR
CHECKMATE PHARMACEUTICALS, INC.
CHARLES ABDALIAN, CHUCK ABDALIAN, BEN AUSPITZ, KAREN BRENNAN, KLEEM CHAUDHARY, PETER COLABUONO, ALAN FUHRMAN, COREY GOODMAN, ART KRIEG, ARTHUR KRIEG, ARTHUR A. KRIEG, ARTHUR M. KRIEG, BARRY LABINGER, JON LIEBER, JONATHAN LIEBER, DAVID MAURO, MICHAEL POWELL, RAMANI VARANASI, ROBERT WEISSKOFF, JAMES WOOLDRIDGE, CHARLES YON
DIRECTOR
KINNATE BIOPHARMA INC.
NIMA W. FARZAN, CARL W. GORDON, STEPHEN W. KALDOR, MARK MELTZ, DEAN MITCHELL, ERIC W. MURPHY, MICHAEL W. ROME, LAURIE SMALDONE ALSUP, JIM TANANBAUM, BRET W. ZBAR
DIRECTOR
SCORPION THERAPEUTICS, INC.
JEFFREY ALBERS, PETER JOSEPH CAMPISI, JR., MARK CHAO, SHELLEY CHU, ANDREW FEDDER, JEAN-FRANCOIS FORMELA, ADAM FRIEDMAN, GARY GLICK, ARJUN GOYAL, ERICA JACKSON, OLEG NODELMAN, BRIAN PIPER, SAURABH SAHA, OTELLO STAMPACCHIA, DARRIN STUART, AMANDA VALENTINO
DIRECTOR
ANTARES THERAPEUTICS, INC.
JEFFREY ALBERS, SHELLEY CHU, ANDREW FEDDER, JEAN-FRANCOIS FORMELA, ADAM FRIEDMAN, MENELAS N. PANGALOS, BRIAN PIPER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-01 
2024-11-22
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-08 
2024-07-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-07-01 
2020-12-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-20 
2020-11-04
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2020-10-26 
2020-08-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-21 
2020-08-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-21 
2020-06-18
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-06-09 
2020-04-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-04-21 
2020-01-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-14 
2019-08-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-14 
2018-05-11
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-30 
2014-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-24 
2013-11-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-11-19